OncBioMune Announces Closing of Asset Purchase Agreement with Theralink Technologies
Avant Diagnostics provides personalized medicine data for physicians and measures the activation state of key drug targets and signaling pathways for Biopharmas through its Theralink® assays The stock will continue to be listed on OTC markets under the symbol “OBMP” Golden, Colorado – June 8, 2020 – OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) (“OncBioMune”) today announced […]
Vivacitas Oncology to Present Phase 2 Clinical Efficacy and Safety Data on AR-67 in Glioblastoma Multiforme (GBM) at the Society for NeuroOncology
Vivacitas Oncology to Present Phase 2 clinical efficacy and safety data on AR-67 in Glioblastoma Multiforme (GBM) at the Soceiety for NeuroOncology (SNO) on November 22, 2019 The team adds Sean Phillips as its Director of Investor Relations [WALNUT CREEK, CALIFORNIA, NOVEMBER 20, 2019] – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a private healthcare […]
World-Renowned Cancer Treatment Expert Joins Vivacitas Oncology As Its Medical Advisor
World-Renowned Cancer Treatment Expert Joins Vivacitas Oncology As Its Medical Advisor Prominent researcher from Sloan-Kettering, Bristol-Meyers Squibb & Spectrum Pharmaceuticals [WALNUT CREEK, CALIFORNIA, May 29, 2019] – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”) continues to confirm the merit of its efforts this week—when Dr. Luigi Lenaz joined the company as its medical advisor. He […]
Vivacitas Oncology Enlists Drug Development Advisor From Johns Hopkins
Vivacitas Oncology Enlists Drug Development Advisor From Johns Hopkins Pharma industry veteran and licensed pharmacist Rajneesh Taneja, PhD. [WALNUT CREEK, California, May 14, 2019] – Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”) continues to attract top talent when it comes to precision drug development. With this week’s addition of scientific advisor Rajneesh Taneja, PhD., the […]